Standardized hemagglutination and hemagglutination-inhibition procedures are described and statistically evaluated for all animal viruses where applicable, except for rubella and the arbovirus group. The standardized tests employ a constant phosphate-buffered saline diluent and constant volumes of serum, antigen, and standardized erythrocyte suspension. The standardized hemagglutination test has a reproducibility of 84 to 96% with adenoviruses, rubeola, and the myxoviruses, and 78 to 93% with reoviruses; the standardized hemagglutination-inhibition test has a reproducibility of 95 to 100% with all viruses tested.
The standardized hemagglutination (HA) and hemagglutination-inhibition (HI) tests consist of two distinct operations: (i) the preparation of standardized erythroctye suspensions, which was described in the preceding paper (5) ; and (ii) the performance and evaluation of the tests, presented in this report. Current HA-HI procedures include a great variety of diluents, volumes, and serum treatments, many of which can be reduced to constant methods. The primary goals of standardizing viral HA-HI tests are therefore to simplify the tests and to provide a statistically sound procedure which is applicable to as many viruscell-serum systems as possible.
Salk's original HA-HI tests (19) have been applied to many other virus-cell or virus-serumcell systems since the discovery of viral hemagglutination by Hirst in 1941. A partial list includes the HA-HI tests for adenoviruses (17, 18) , enteroviruses (4, 10, 11) , reoviruses (3, 14) , myxoviruses (9, 13, 15) , poxviruses (8, 26) , and some of the murine viruses (12, 24) . The reproducibility of any of these HA or HI methods, considered as a test procedure, has not been reported in depth. Evaluations of HA-HI tests have been reported, however, by way of comparison of the diagnostic results of the HA-HI tests to serum neutralization and complement-fixation tests (4, 16, 20, 26) .
The standardized HA and HI tests described in this report will apply to the following viruses: the hemagglutinating strains of coxsackie and echoviruses; the murine encephalomyelitis viruses; reovirus types 1, 2, and 3; influenza A, B, and C; mumps; Newcastle disease virus (NDV); all strains of parainfluenza 1, 2, 3, and 4; murine pneumonia virus (PVM); two strains of coronavirus; rubeola; smallpox, vaccinia, and other variola-like viruses; ectromelia of mice; adenovirus groups 1, 11, and III; polyoma and K virus; the murine H viruses, X14, and rat virus (RV). The standardized tests can also be used for other lower animal viruses and for some of the Bedsonia group which hemagglutinate red blood cells. We have not included rubella and the arboviruses in the standardization efforts at this time but hope to do so at a later date.
Additional information on the hemagglutination properties of the viruses discussed in this report may be found in several excellent reference works (1, 7, 13, 25) . These works should be consulted for details on virus strain peculiarities and preparation of HA antigens, and for the complete lists of references included with the pertinent chapters.
MATERIALS AND METHODS
Microtiter technique. The standardized HA-HI tests were performed in the microtiter system de- scribed by Sever (21) . Flexible vinyl "U" and "V" plates (Cooke Engineering Co., Alexandria, Va.; no. 220-24 and 220-25, respectively) and rigid styrene "U" and "V" plates (Linbro Chemical Co., New Haven, Conn.; no. IS-MRC-96 and IS-MVC-96, respectively) were evaluated during the development of the tests. Antigens and sera were diluted in the wells with stainless steel "tulip" loops (Cooke no. 220-33 and 220-34). At the start of the incubation period, the plates were sealed with transparent tape (Cooke no. 220-12) to retard evaporation.
Diluents. A large number of diluents were evaluated (see Table 1 ) to find the one best suited or at 824 VIRAL HEMAGGLUTINATION TESTS. II least adequate for all systems studied in this report. The one ultimately chosen was 0.01 M phosphatebuffered saline (PBS), pH 7.2, containing 0.010 M total P04 and 0.146 M NaCl, and with an ionic strength of 0.171. This buffer was modified by the addition of adenovirus type 6 equine antiserum (adsorbed with rat erythrocytes) to a final concentration of 1.0%o by volume for HA-HI tests with the group III adenoviruses, or by the addition of bovine serum albumin (BSA) fraction V powder to a final concentration of 0.1% (w/v) for HA-HI tests with several of the murine viruses. The basic PBS diluent was used throughout the study for preparing red blood cell (RBC) suspensions, virus dilutions in the HA test, serum dilutions, and the 8 HA unit virus suspension in the HI test; it also served as the diluent in the kaolin and receptor-destroying enzyme (RDE) treatments of sera.
Antigens and antisera. The antigens used throughout this study were harvests of virus-infected tissue culture or embryonated chicken eggs. All harvest materials were clarified by centrifugation at 1,200 X g for 10 min and at 4 C. The viruses used were prototype strains procured from the Biological Reagents Section, Laboratory Division, National Communicable Disease Center (NCDC).
Antisera used in the HI test were procured from the Biological Reagents Section, NCDC. All sera were heated at 56 C for 30 min and initially diluted 1: 5 Comparative tests were conducted to determine whether 0.05 ml of a 0.4% mammalian cell suspension could substitute for 0.025 ml of a 1.0% suspension of cells. Adenoviruses 3, 5, 7, 9, 10, and 13, echovirus 6, and reovirus 3 were titrated in both systems in duplicate. In every test, the end point of agglutination in the 0.4% system was clearly readable and was the same or one dilution higher than the titer in the 1.0% system. We consistently noticed a higher titer for the adenoviruses when 0.05 ml of 0.4% suspensions was employed. However, the larger volume required an additional 5 min for the cells to settle. It therefore appears that the 0.4% cell system is more sensitive than the 1.0% system for mammalian cells.
On the basis of these results, the standardized HA test was designed to employ avian cells at a 0.5 % concentration and mammalian cells at 0.4%. The microtiter HA system would then employ 0.05 ml of cells added to 0.05 ml of virus dilution. The microtiter HI test would employ 0.025 ml of serum dilution plus 0.025 ml of the virus suspension containing 4 HA units (8 HA units per 0.05 ml); after 40-to 60-min incubation period, 0.05 ml of the appropriate cell suspension would be added.
Treatment of sera for the HI test. Longstanding procedures for adenovirus and measles (rubeola) HI tests include the extraction of sera with kaolin (13, 18) . Preliminary observations in our laboratory, however, indicated that kaolin treatment might not be necessary as a routine procedure. We conducted a series of experiments to establish this point.
Ninety-five preimmune horse sera from an adenovirus 1 to 31 immunization series were tested by HI against 28 of these adenovirus types. The sera were heated at 56 C for 30 min, diluted 1:5 as the starting dilution, and adsorbed with 50% rat or rhesus erythrocytes. Kaolin was not used. In 2,700 tests, none of these preimmune sera showed any nonspecific inhibition activity.
Further testing was done with human, rabbit, and guinea pig preimmune sera. Several hundred human sera, 60 rabbit sera, and 40 guinea pig sera have been tested over a 3-year period with many adenovirus types. Again, these were heat-treated and adsorbed with the appropriate red cells but were not adsorbed with kaolin. In approximately 2,000 tests, none of these preimmune sera contained nonspecific viral HA inhibitors that were not removed by heating and cell adsorption.
Similar experience has suggested that kaolin treatment is not required for measles HI tests. During the same 3-year period, over 700 human, 25 monkey, and 10 goat sera have been used satisfactorily in measles HI tests with heating and cell adsorption but without kaolin.
The use of kaolin or similar treatment, such as Rivanol (23), is necessary for enterovirus and reovirus human and animal sera, with the possible exception of reovirus chicken antiserum, which appears to be best treated by human RBC adsorption instead of kaolin or kaolin plus erythrocytes. RDE generally replaces the heat-trypsin-periodate treatment formerly employed for myxovirus HI tests (15) .
Adsorption of the serum with the species of red cells to be used in the HI test is often necessary. Three general rules may be followed. Reproducibility. In most tests in which a twofold dilution scheme is used, fourfold or greater changes in titer (differences of two or more dilutions) on serial specimens from one patient (e.g., acute and convalescent sera) are considered diagnostically or clinically significant. That is, changes in titer greater than twofold (one dilution) are implicitly and explicitly interpreted as "real." Therefore, a useful expression for reproducibility of titers should be related to this criterion of clinical significance.
This can be done by determining on an appropriate number of blind duplicate specimens the percentage of duplicate titers that differ by two or more dilutions (fourfold or greater changes). This percentage is the false-positive rate for the test based on fourfold or greater changes. The reproducibility of the test can be expressed as the converse of the false-positive rate-that is, the percentage of duplicate titers that are the same (excluding specimens negative on both duplicates) or differ by one dilution. Duplicates analyzed on the same day (run) can be used to estimate within-day reproducibility; duplicates analyzed on different days can be used to estimate day-to-day reproducibility. This is the approach used in this evaluation.
Within-day and day-to-day reproducibility of the standardized HA and HI microtiter tests were evaluated by use of coded "blind" specimens. Table 4 . Other components (for example, buffer) of the test remained unchanged. As expected, the effects of day-to-day variation and different cell lots decreased the reproducibility of titers. In both tests and virus groups, the percentage of duplicates with the same titer was lower for day-to-day duplicates than for within-day duplicates. Day-to-day reproducibility was lower than within-day reproducibility by as much as 10.6 percentage points for the HA tests on the adenoviruses and rubeola; however, this relatively large decrease was due primarily to one lot of cells that yielded titers consistently higher than the other three lots. As with the within-day results, day-to-day agreement of the HI test was better than that of the HA test, and myxovirus titers were more reproducible than adenovirus-rubeola titers.
The results in Table 5 are similar to those in Table 4 except that agreement of duplicate titers was affected by different lots of the buffer rather than different cells on each day. The use of different buffer lots affected day-to-day reproducibility about as much as did the use of different cells. With the exception of adenovirus and measles HA titers, the percentages in similar categories in Tables 4 and 5 are equal. Again, the HI test and the myxovirus HA and HI titers appear to be more reproducible than the HA test and the adenovirus or rubeola HA and HI titers.
Experimental design of reovirus tests. Estimates of reproducibility were obtained from approximately 60 duplicate determinations of both hemagglutinin and serum titers. The HA tests were performed on duplicate samples of 10 positive and 2 negative specimens with each of two cell lots on each of 3 days; the HI tests were performed on duplicate samples of 14 positive and 2 negative sera with each of two cell lots on each of 2 days. One lot of basic PBS buffer and two lots of cells were used altogether, as indicated in Fig. 2 . The two lots of human "O" erythrocytes were collected at the start of the evaluation and were used throughout the week of testing, with a portion being washed and standardized each day.
The antigens consisted of four lots of reovirus type 1, four of type 2, and two of type 3, all harvested from rhesus or A rican green monkey kidney tissue culture. The HA titer range was 1:10 to 1:160 for the positive antigens and was consistently < 1 :2.5 for two negative control anti- significant. Apparently, the use of different cells has little or no effect on within-day reproducibility of reovirus HA and HI titers.
The day-to-day agreement of titers for the two tests in which the same cells and buffer lots were used on both duplicates of a pair is summarized in Table 8 . If only the reproducibility estimates (77.5% for HA and 96.4 % for HI) in Table 8 are considered, day to-day reproducibility of each test is not significantly different from within-day reproducibility. However, differences between the percentages occurring in each category of agreement are significant. That is, day-to-day variation significantly reduced the percentage of duplicates with identical titers, but only to the extent that Table 6 , footnote a-.I aSee Table 6 , footnote a.
bSee Table 6 , footnote b. (27) showed that the normal sera of rabbits, chickens, rats, guinea pigs, and horses contain both thermolabile and thermostable inhibitors, the latter being removable by kaolin in most cases. Human sera also contained thermostable inhibitors against several of the adenovirus types, although to much lower titers than some of the animal sera. Their 
